# Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

> **NCT02726867** · PHASE3 · WITHDRAWN · sponsor: **Mid-Atlantic Epilepsy and Sleep Center, LLC**

## Conditions studied

- Epilepsy
- Status Epilepticus

## Interventions

- **DRUG:** levetiracetam
- **DRUG:** lacosamide
- **DRUG:** Ketamine
- **DRUG:** Phenobarbital

## Key facts

- **NCT ID:** NCT02726867
- **Lead sponsor:** Mid-Atlantic Epilepsy and Sleep Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02726867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02726867, "Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02726867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*